Quantcast

Latest Carbapenem antibiotics Stories

2013-07-19 14:38:41

Global structural properties have changed across bacterial families without putting limits on new antibiotic resistance Antibiotic-resistant bacteria have been emerging at an alarming rate. In some of the scariest of these pathogens, the mechanism responsible for the bacteria's ability to defeat antibiotics is a complex protein molecule embedded in the bacterial cell wall -- the enzyme β-lactamase. The rapid evolution of β-lactamase is the key factor responsible...

2012-02-14 00:04:28

North Carolina State University chemists have created a compound that makes existing antibiotics 16 times more effective against recently discovered antibiotic-resistant “superbugs.” These so-called superbugs are actually bacterial strains that produce an enzyme known as New Delhi metallo-β-lactamase (NDM-1). Bacteria that produce this enzyme are practically impervious to antibiotics because NDM-1renders certain antibiotics unable to bind with their bacterial targets....

2010-06-23 06:16:00

VIENNA, Austria, June 23, 2010 /PRNewswire/ -- EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand. Beta-lactamases are enzymes that inactivate beta-lactam antibiotics, hydrolyzing the beta-lactam ring, a molecular structure common to these drugs. This...

2010-06-22 10:29:00

LAKE FOREST, Ill., June 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were...

2010-05-17 07:00:00

MALVERN, Pa., May 17 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that surveyed clinicians cite extended-spectrum beta-lactamase (ESBL)-producing E. coli and K. pneumoniae as the most concerning resistant pathogens in hospital-acquired gram-negative infections. These pathogens are resistant to commonly prescribed first-line antibiotics (e.g., penicillins, cephalosporins), and...

2010-03-15 11:10:00

SHENZHEN, CHINA, March 15 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) is pleased to announce that the Chilean government approved two of the company's penem injectables. Following 18 months of testing and negotiations, Chilean ISP (Ministry of Health) approved two of HTDS' penem injectables, Meropenem for Injection (MEINEN) and Imipenem for Injection (IMINEN). HTDS received the registration certificate for these two medications from the Chilean ISP and...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related